Literature DB >> 34258736

An Update on Antiretroviral Therapy.

Luis Menéndez-Arias1, Samara Martín-Alonso2, Estrella Frutos-Beltrán2.   

Abstract

Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) still claim many lives across the world. However, research efforts during the last 40 years have led to the approval of over 30 antiretroviral drugs and the introduction of combination therapies that have turned HIV infection into a chronic but manageable disease. In this chapter, we provide an update on current available drugs and treatments, as well as future prospects towards reducing pill burden and developing long-acting drugs and novel antiretroviral therapies. In addition, we summarize efforts to cure HIV, including pharmaceutical strategies focused on the elimination of the virus.
© 2021. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Antiretroviral drug; Combination therapy; Drug resistance; Eradication; HIV; Toxicity

Year:  2021        PMID: 34258736     DOI: 10.1007/978-981-16-0267-2_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  111 in total

Review 1.  HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies.

Authors:  Josef Eberle; Lutz Gürtler
Journal:  Intervirology       Date:  2012-01-24       Impact factor: 1.763

Review 2.  Viral reverse transcriptases.

Authors:  Luis Menéndez-Arias; Alba Sebastián-Martín; Mar Álvarez
Journal:  Virus Res       Date:  2016-12-30       Impact factor: 3.303

Review 3.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

Review 4.  Targeting HIV: antiretroviral therapy and development of drug resistance.

Authors:  Luis Menéndez-Arias
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

Review 5.  Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.

Authors:  Luis Menéndez-Arias
Journal:  Antiviral Res       Date:  2013-02-08       Impact factor: 5.970

Review 6.  HIV treatment and prevention 2019: current standards of care.

Authors:  Nittaya Phanuphak; Roy M Gulick
Journal:  Curr Opin HIV AIDS       Date:  2020-01       Impact factor: 4.283

Review 7.  HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Viruses       Date:  2011-07-08       Impact factor: 5.048

8.  Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017.

Authors:  Laura Dwyer-Lindgren; Michael A Cork; Amber Sligar; Krista M Steuben; Kate F Wilson; Naomi R Provost; Benjamin K Mayala; John D VanderHeide; Michael L Collison; Jason B Hall; Molly H Biehl; Austin Carter; Tahvi Frank; Dirk Douwes-Schultz; Roy Burstein; Daniel C Casey; Aniruddha Deshpande; Lucas Earl; Charbel El Bcheraoui; Tamer H Farag; Nathaniel J Henry; Damaris Kinyoki; Laurie B Marczak; Molly R Nixon; Aaron Osgood-Zimmerman; David Pigott; Robert C Reiner; Jennifer M Ross; Lauren E Schaeffer; David L Smith; Nicole Davis Weaver; Kirsten E Wiens; Jeffrey W Eaton; Jessica E Justman; Alex Opio; Benn Sartorius; Frank Tanser; Njeri Wabiri; Peter Piot; Christopher J L Murray; Simon I Hay
Journal:  Nature       Date:  2019-05-15       Impact factor: 49.962

Review 9.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

Review 10.  Foamy virus zoonotic infections.

Authors:  Delia M Pinto-Santini; Carolyn R Stenbak; Maxine L Linial
Journal:  Retrovirology       Date:  2017-12-02       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.